Alexandre Akoulitchev

Company: Oxford BioDynamics plc

Job title: Chief Scientific Officer

Seminars:

Liquid Biopsy with 3D Genomic Biomarkers as a Clinical Tool for Diagnostic, Prognostic & Predictive Patient Stratifications 1:55 pm

3D Genomic EpiSwitch® blood-based biomarkers: from abnormal 3D genome architecture to pathological outcomes, with clinical tests for early diagnosis, prognosis and prediction of response to treatment Checkpoint Inhibitor Response Test (CiRT): translation into practice for pan-cancer immune-oncology therapy ALS diagnostic and prognostic EpiSwitch® tests: from development to deployment in MTPA Radicava trialRead more

day: Day Two Track A PM